Like I say - I dunno. Could be the FDA Class I non-filing justification won't require further trials; could be the roll-out in Asia will take care of a lot of evidence; could be the FDA Class II already in hand, with a plan to initially sell to physicians, is why they have personnel in place in the U.S. for that goal. I dunno. Could be pretty much anything. But try to think big.
News 
Market Data 
Discover 
